Teva Pharmaceutical Industries Revenue 2010-2024 | TEVA

Teva Pharmaceutical Industries revenue for the twelve months ending September 30, 2024 was $16.772B, a 9.82% increase year-over-year.

  • Teva Pharmaceutical Industries annual revenue for 2023 was $15.846B, a 6.17% increase from 2022.
  • Teva Pharmaceutical Industries annual revenue for 2022 was $14.925B, a 6% decline from 2021.
  • Teva Pharmaceutical Industries annual revenue for 2021 was $15.878B, a 4.69% decline from 2020.

Teva Pharmaceutical Industries Revenue 2010-2024 | TEVA

  • Teva Pharmaceutical Industries annual revenue for 2023 was $15.846B, a 6.17% increase from 2022.
  • Teva Pharmaceutical Industries annual revenue for 2022 was $14.925B, a 6% decline from 2021.
  • Teva Pharmaceutical Industries annual revenue for 2021 was $15.878B, a 4.69% decline from 2020.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$12B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Sol-Gel Technologies (SLGL)$12M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M